StockWatch
·
HomeLiveWeekly

VENUS REMEDIES LTD.

BSE: 526953

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-28.2080.02188.25296.47Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
2.5510.2417.9225.61Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue259.01+43.9%179.95-6.6%192.65+46.1%131.85-32.1%194.04+12.5%172.54+3.3%167.02
Other Income4.64+92.5%2.41+43.5%1.68-79.0%8.00+18.2%6.77+289.1%1.74-83.8%10.71
Total Income263.65+44.6%182.36-6.2%194.33+39.0%139.85-30.4%200.81+15.2%174.28-1.9%177.73
EXPENSES
Expenditure206.07+37.8%149.55-11.4%168.73+34.8%125.15-28.9%175.98+13.7%154.83-5.0%162.92
Tax14.11+78.8%7.89+24.1%6.36+111.3%3.01-57.7%7.11+34.7%5.28-4.9%5.55
PROFIT
PBT57.58+75.5%32.81+28.2%25.60+74.1%14.70-40.8%24.83-15.4%29.36+98.2%14.81
Net Profit43.47+74.4%24.92+29.5%19.24+64.6%11.69-21.0%14.79-38.6%24.08+160.0%9.26
KEY METRICS
OPM %22.95%+2.54pp20.41%+4.92pp15.49%+5.90pp9.59%-2.03pp11.62%——
NPM %16.49%+2.82pp13.67%+3.77pp9.90%+1.54pp8.36%+0.99pp7.37%-6.45pp13.82%+8.61pp5.21%
EPS32.51+74.4%18.64+29.4%14.40+64.6%8.75-21.0%11.07-38.6%18.02+160.4%6.92

Corporate Events

DividendVENUSREM
2026
7Aug

₹10 / share

BSE Filing ↗
Board MeetingVENUSREM
2026
26May

Board Meeting

The board meeting is scheduled to consider and approve audit…

BSE Filing ↗
Board MeetingVENUSREM
2025
10Nov

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing ↗
Board MeetingVENUSREM
2025
4Feb

Board Meeting

Considering and approving Unaudited Standalone and Consolida…

BSE Filing ↗
Board MeetingVENUSREM
2024
29Oct

Board Meeting

Considering and approving the Unaudited Standalone and Conso…

BSE Filing ↗
Board MeetingVENUSREM
2024
20Jul

Board Meeting

Consideration of appointment of independent director, finali…

BSE Filing ↗
Board MeetingVENUSREM
2024
30May

Board Meeting

To consider and approve Audited Standalone and Consolidated …

BSE Filing ↗
Board MeetingVENUSREM
2023
9Nov

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing ↗